RFA
VRTX icon

Reyes Financial Architecture’s Vertex Pharmaceuticals VRTX Stock Holding History

Reyes Financial Architecture’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97K Hold
8
– – ﹤0.01% 287
2026
Q1 		$3.57K Sell
8
-7
-47% -$3.26K ﹤0.01% 311
2025
Q4 		$6.8K Buy
15
+7
+88% +$3.02K ﹤0.01% 271
2025
Q3 		$3.13K Hold
8
– – ﹤0.01% 285
2025
Q2 		$3.56K Hold
8
– – ﹤0.01% 259
2025
Q1 		$3.88K Buy
+8
New +$3.73K ﹤0.01% 268

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Reyes Financial Architecture's VRTX Position: Q2 2026 in Review

Reyes Financial Architecture held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 8 shares worth $3.97K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Reyes Financial Architecture first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.8K in Q4 2025. 252 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Reyes Financial Architecture held 8 shares of Vertex Pharmaceuticals worth $3.97K as of Q2 2026.
  • Reyes Financial Architecture left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Reyes Financial Architecture's portfolio in Q2 2026, its #287 holding.
  • Reyes Financial Architecture first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Reyes Financial Architecture's Vertex Pharmaceuticals position peaked at $6.8K in Q4 2025.
  • 252 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Reyes Financial Architecture's 13F filing for Q2 2026, filed 17 Jul 2026.